Glenmark and Ichnos take a collaborative leap to accelerate innovation in Cancer Treatment with their alliance ‘Ichnos Glenmark Innovation’ – Business Standard

Glenmark Pharmaceuticals Ltd. (Glenmark), a leading, research-driven, global pharmaceutical company, and Ichnos Sciences Inc. (Ichnos), its global fully integrated, clinical-stage biotech subsidiary, today announced the launch of their alliance Ichnos Glenmark Innovation to accelerate new drug discovery in cancer treatment.